599 related articles for article (PubMed ID: 33328056)
1. Artificial intelligence for teleophthalmology-based diabetic retinopathy screening in a national programme: an economic analysis modelling study.
Xie Y; Nguyen QD; Hamzah H; Lim G; Bellemo V; Gunasekeran DV; Yip MYT; Qi Lee X; Hsu W; Li Lee M; Tan CS; Tym Wong H; Lamoureux EL; Tan GSW; Wong TY; Finkelstein EA; Ting DSW
Lancet Digit Health; 2020 May; 2(5):e240-e249. PubMed ID: 33328056
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of a National Telemedicine Diabetic Retinopathy Screening Program in Singapore.
Nguyen HV; Tan GS; Tapp RJ; Mital S; Ting DS; Wong HT; Tan CS; Laude A; Tai ES; Tan NC; Finkelstein EA; Wong TY; Lamoureux EL
Ophthalmology; 2016 Dec; 123(12):2571-2580. PubMed ID: 27726962
[TBL] [Abstract][Full Text] [Related]
3. An observational study to assess if automated diabetic retinopathy image assessment software can replace one or more steps of manual imaging grading and to determine their cost-effectiveness.
Tufail A; Kapetanakis VV; Salas-Vega S; Egan C; Rudisill C; Owen CG; Lee A; Louw V; Anderson J; Liew G; Bolter L; Bailey C; Sadda S; Taylor P; Rudnicka AR
Health Technol Assess; 2016 Dec; 20(92):1-72. PubMed ID: 27981917
[TBL] [Abstract][Full Text] [Related]
4. Telemedicine-based digital retinal imaging vs standard ophthalmologic evaluation for the assessment of diabetic retinopathy.
Li Z; Wu C; Olayiwola JN; Hilaire DS; Huang JJ
Conn Med; 2012 Feb; 76(2):85-90. PubMed ID: 22670358
[TBL] [Abstract][Full Text] [Related]
5. Artificial intelligence using deep learning to screen for referable and vision-threatening diabetic retinopathy in Africa: a clinical validation study.
Bellemo V; Lim ZW; Lim G; Nguyen QD; Xie Y; Yip MYT; Hamzah H; Ho J; Lee XQ; Hsu W; Lee ML; Musonda L; Chandran M; Chipalo-Mutati G; Muma M; Tan GSW; Sivaprasad S; Menon G; Wong TY; Ting DSW
Lancet Digit Health; 2019 May; 1(1):e35-e44. PubMed ID: 33323239
[TBL] [Abstract][Full Text] [Related]
6. Automated Diabetic Retinopathy Image Assessment Software: Diagnostic Accuracy and Cost-Effectiveness Compared with Human Graders.
Tufail A; Rudisill C; Egan C; Kapetanakis VV; Salas-Vega S; Owen CG; Lee A; Louw V; Anderson J; Liew G; Bolter L; Srinivas S; Nittala M; Sadda S; Taylor P; Rudnicka AR
Ophthalmology; 2017 Mar; 124(3):343-351. PubMed ID: 28024825
[TBL] [Abstract][Full Text] [Related]
7. The cost-utility of telemedicine to screen for diabetic retinopathy in India.
Rachapelle S; Legood R; Alavi Y; Lindfield R; Sharma T; Kuper H; Polack S
Ophthalmology; 2013 Mar; 120(3):566-573. PubMed ID: 23211635
[TBL] [Abstract][Full Text] [Related]
8. Prospective evaluation of an artificial intelligence-enabled algorithm for automated diabetic retinopathy screening of 30 000 patients.
Heydon P; Egan C; Bolter L; Chambers R; Anderson J; Aldington S; Stratton IM; Scanlon PH; Webster L; Mann S; du Chemin A; Owen CG; Tufail A; Rudnicka AR
Br J Ophthalmol; 2021 May; 105(5):723-728. PubMed ID: 32606081
[TBL] [Abstract][Full Text] [Related]
9. Tele-ophthalmology screening for proliferative diabetic retinopathy in urban primary care offices: an economic analysis.
Brady CJ; Villanti AC; Gupta OP; Graham MG; Sergott RC
Ophthalmic Surg Lasers Imaging Retina; 2014; 45(6):556-61. PubMed ID: 25423636
[TBL] [Abstract][Full Text] [Related]
10. Review of economic evaluations of teleophthalmology as a screening strategy for chronic eye disease in adults.
Sharafeldin N; Kawaguchi A; Sundaram A; Campbell S; Rudnisky C; Weis E; Tennant MTS; Damji KF
Br J Ophthalmol; 2018 Nov; 102(11):1485-1491. PubMed ID: 29680803
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of implementing automated grading within the national screening programme for diabetic retinopathy in Scotland.
Scotland GS; McNamee P; Philip S; Fleming AD; Goatman KA; Prescott GJ; Fonseca S; Sharp PF; Olson JA
Br J Ophthalmol; 2007 Nov; 91(11):1518-23. PubMed ID: 17585001
[TBL] [Abstract][Full Text] [Related]
12. Cost-Effectiveness of Screening for Intermediate Age-Related Macular Degeneration during Diabetic Retinopathy Screening.
Chan CK; Gangwani RA; McGhee SM; Lian J; Wong DS
Ophthalmology; 2015 Nov; 122(11):2278-85. PubMed ID: 26315045
[TBL] [Abstract][Full Text] [Related]
13. Preventing diabetes blindness: cost effectiveness of a screening programme using digital non-mydriatic fundus photography for diabetic retinopathy in a primary health care setting in South Africa.
Khan T; Bertram MY; Jina R; Mash B; Levitt N; Hofman K
Diabetes Res Clin Pract; 2013 Aug; 101(2):170-6. PubMed ID: 23796361
[TBL] [Abstract][Full Text] [Related]
14. Diabetic retinopathy screening: a systematic review of the economic evidence.
Jones S; Edwards RT
Diabet Med; 2010 Mar; 27(3):249-56. PubMed ID: 20536486
[TBL] [Abstract][Full Text] [Related]
15. Six-year prevalence and incidence of diabetic retinopathy and cost-effectiveness of tele-ophthalmology in Manitoba.
Kanjee R; Dookeran RI; Mathen MK; Stockl FA; Leicht R
Can J Ophthalmol; 2017 Nov; 52 Suppl 1():S15-S18. PubMed ID: 29074007
[TBL] [Abstract][Full Text] [Related]
16. Cost Analysis of Teleophthalmology Screening for Diabetic Retinopathy Using Teleophthalmology Billing Codes.
Ellis MP; Bacorn C; Luu KY; Lee SC; Tran S; Lillis C; Lim MC; Yiu G
Ophthalmic Surg Lasers Imaging Retina; 2020 May; 51(5):S26-S34. PubMed ID: 32484898
[TBL] [Abstract][Full Text] [Related]
17. DrishtiCare: a telescreening platform for diabetic retinopathy powered with fundus image analysis.
Joshi GD; Sivaswamy J
J Diabetes Sci Technol; 2011 Jan; 5(1):23-31. PubMed ID: 21303621
[TBL] [Abstract][Full Text] [Related]
18. Costs and consequences of automated algorithms versus manual grading for the detection of referable diabetic retinopathy.
Scotland GS; McNamee P; Fleming AD; Goatman KA; Philip S; Prescott GJ; Sharp PF; Williams GJ; Wykes W; Leese GP; Olson JA;
Br J Ophthalmol; 2010 Jun; 94(6):712-9. PubMed ID: 19965826
[TBL] [Abstract][Full Text] [Related]
19. Teleophthalmology Screening for Diabetic Retinopathy in Brazil: Applicability and Economic Assessment.
Souza GF; Figueira RM; Alkmim MB; Sousa LAP; Bonisson L; Ribeiro ALP; Vasconcelos-Santos DV
Telemed J E Health; 2020 Mar; 26(3):341-346. PubMed ID: 30994411
[No Abstract] [Full Text] [Related]
20. Cost-utility Analysis of Opportunistic and Systematic Diabetic Retinopathy Screening Strategies from the Perspective of the Brazilian Public Healthcare System.
Ben ÂJ; Neyeloff JL; de Souza CF; Rosses APO; de Araujo AL; Szortika A; Locatelli F; de Carvalho G; Neumann CR
Appl Health Econ Health Policy; 2020 Feb; 18(1):57-68. PubMed ID: 31674001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
